NeuroOne Medical Technologies Corporation
NMTC
$0.7716
-$0.009-1.15%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 105.39% | 0.68% | 234.92% | -63.29% | 31.10% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 105.39% | 0.68% | 234.92% | -63.29% | 31.10% |
Cost of Revenue | 12.95% | -36.97% | 14.80% | -46.52% | -23.67% |
Gross Profit | 70.67% | 128.11% | 162.01% | 38.66% | 44.60% |
SG&A Expenses | -13.93% | -3.12% | -5.98% | 16.80% | 1.00% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -1.02% | -4.62% | -64.22% | -20.93% | -12.57% |
Operating Income | 32.47% | 7.14% | 150.47% | 11.00% | 20.41% |
Income Before Tax | 45.77% | 20.47% | 153.37% | -6.87% | 20.22% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 45.77% | 20.47% | 153.37% | -6.87% | 20.22% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 45.77% | 20.47% | 153.37% | -6.87% | 20.22% |
EBIT | 32.47% | 7.14% | 150.47% | 11.00% | 20.41% |
EBITDA | 33.35% | 7.46% | 153.31% | 11.27% | 20.92% |
EPS Basic | 69.47% | 33.76% | 141.54% | 20.17% | 48.71% |
Normalized Basic EPS | 62.97% | 22.35% | 141.56% | 21.83% | 48.74% |
EPS Diluted | 69.47% | 33.76% | 141.36% | 20.17% | 48.71% |
Normalized Diluted EPS | 62.97% | 22.35% | 141.45% | 21.83% | 48.74% |
Average Basic Shares Outstanding | 77.70% | 20.07% | 28.51% | 33.90% | 55.60% |
Average Diluted Shares Outstanding | 77.70% | 20.07% | 28.69% | 33.90% | 55.60% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |